Suppr超能文献

虚拟助手对尼古丁替代疗法相关问题的回应:一项混合方法分析。

Virtual Assistants' Response to Queries About Nicotine Replacement Therapy: A Mixed-Method Analysis.

作者信息

Amin Samia, Uyeda Kylie, Pagano Ian, Tabangcura Kayzel R, Taketa Rachel, Terawaki Kawamoto Crissy, Pokhrel Pallav

机构信息

University of Hawai'i Cancer Center, USA.

出版信息

Eval Health Prof. 2025 Jun;48(2):174-181. doi: 10.1177/01632787241235689. Epub 2024 Feb 26.

Abstract

This study focused on investigating the potential of Artificial Intelligent-powered Virtual Assistants (VAs) such as Amazon Alexa, Apple Siri, and Google Assistant as tools to help individuals seeking information about Nicotine Replacement Treatment (NRT) for smoking cessation. The researchers asked 40 NRT-related questions to each of the 3 VAs and evaluated the responses for voice recognition. The study used a cross-sectional mixed-method design with a total sample size of 360 responses. Inter-rater reliability and differences between VAs' responses were examined by SAS software, and qualitative assessments were conducted using NVivo software. Google Assistant achieved 100% voice recognition for NRT-related questions, followed by Apple Siri at 97.5%, and Amazon Alexa at 83.3%. Statistically significant differences were found between the responses of Amazon Alexa relative to both Google Assistant and Apple Siri. Researcher 1's ratings significantly differed from Researcher 2's ( = .001), but not from Researcher 3's ( = .11). Virtual Assistants occasionally struggled to understand the context or nuances of questions, lacked in-depth information in their responses, and provided generic or unrelated responses. Virtual Assistants have the potential to be incorporated into smoking cessation interventions and tobacco control initiatives, contingent upon improving their competencies.

摘要

本研究聚焦于调查诸如亚马逊Alexa、苹果Siri和谷歌助手等人工智能驱动的虚拟助手作为工具,帮助寻求戒烟尼古丁替代疗法(NRT)信息的个人的潜力。研究人员向3个虚拟助手分别提出40个与NRT相关的问题,并评估语音识别的回答。该研究采用横断面混合方法设计,总样本量为360个回答。通过SAS软件检查评分者间信度和虚拟助手回答之间的差异,并使用NVivo软件进行定性评估。谷歌助手对NRT相关问题的语音识别率达到100%,其次是苹果Siri,为97.5%,亚马逊Alexa为83.3%。发现亚马逊Alexa的回答与谷歌助手和苹果Siri的回答之间存在统计学显著差异。研究人员1的评分与研究人员2的评分有显著差异( = 0.001),但与研究人员3的评分无显著差异( = 0.11)。虚拟助手偶尔难以理解问题的背景或细微差别,回答中缺乏深入信息,并提供一般性或不相关的回答。虚拟助手有潜力被纳入戒烟干预措施和烟草控制倡议,但前提是要提高其能力。

相似文献

2
Interventions to reduce harm from continued tobacco use.减少持续吸烟危害的干预措施。
Cochrane Database Syst Rev. 2016 Oct 13;10(10):CD005231. doi: 10.1002/14651858.CD005231.pub3.
4
Nicotine replacement therapy versus control for smoking cessation.尼古丁替代疗法与对照用于戒烟
Cochrane Database Syst Rev. 2018 May 31;5(5):CD000146. doi: 10.1002/14651858.CD000146.pub5.
5
Interventions for preventing weight gain after smoking cessation.戒烟后预防体重增加的干预措施。
Cochrane Database Syst Rev. 2012 Jan 18;1:CD006219. doi: 10.1002/14651858.CD006219.pub3.
6
Pharmacological interventions for smoking cessation: an overview and network meta-analysis.戒烟的药物干预:综述与网状Meta分析
Cochrane Database Syst Rev. 2013 May 31;2013(5):CD009329. doi: 10.1002/14651858.CD009329.pub2.
7
Interventions for preventing weight gain after smoking cessation.戒烟后预防体重增加的干预措施。
Cochrane Database Syst Rev. 2009 Jan 21(1):CD006219. doi: 10.1002/14651858.CD006219.pub2.
8
Pharmacological interventions for promoting smoking cessation during pregnancy.孕期促进戒烟的药物干预措施。
Cochrane Database Syst Rev. 2015 Dec 22(12):CD010078. doi: 10.1002/14651858.CD010078.pub2.
9
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2016 May 9;2016(5):CD006103. doi: 10.1002/14651858.CD006103.pub7.
10
Nicotine receptor partial agonists for smoking cessation.用于戒烟的尼古丁受体部分激动剂。
Cochrane Database Syst Rev. 2012 Apr 18(4):CD006103. doi: 10.1002/14651858.CD006103.pub6.

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验